Today’s ruling on commercial speech will rein in FDA’s regulatory overreach
A major Federal Court ruling today could significantly impact FDA regulation of commercial speech (and of drugs). The agency may no longer be able to exert its regulatory authority over drugs by simply restricting the flow of certain “unapproved” scientific … read more









